Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio. Headquartered in Switzerland, Windward Bio is a ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

In an age where pharmaceuticals dominate the shelves, it's easy to overlook the potent remedies that nature offers, often ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...

Verona Pharma (VRNA) stock in focus as company reports early sales for Q4 and 2024 thanks to its lung disease therapy ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

"This will allow Koye to develop solutions that help track and treat respiratory health in COPD patients using their voice," said the pharma company in a statement. The two companies plan to ...

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...